Clincosm LogoSign in Get a demo

squamous cell lung cancer

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)

Active, not recruiting
  • Squamous Cell Lung Cancer
  • +5 more
  • pembrolizumab; vorinostat
  • Angers, France
  • +13 more
Jan 4, 2023

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Squamous Cell Lung Cancer Trial in United States (ZEN003694)

Recruiting
  • Squamous Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Nov 1, 2022

APOLLO 11, Consortium of Italian Centers Involved in Treatment

Not yet recruiting
  • NSCLC
  • +4 more
    • (no location specified)
    Sep 19, 2022

    Subjects Treated With Autologous T Cells Using Sleeping Beauty

    Not yet recruiting
    • Gynecologic Cancer
    • +9 more
    • Neoantigen specific TCR-T cell drug product
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

    Recruiting
    • Gynecologic Cancer
    • +11 more
    • Neoantigen specific TCR-T cell drug product
    • Aldesleukin (IL-2)
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Non-Squamous NSCLC (NSCLC), Adenocarcinoma of the Lung, Lung Cancer Trial in United States (Docetaxel, Nivolumab, Gemcitabine)

    Terminated
    Has Results
    • Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
    • +3 more
    • Anderson, Indiana
    • +8 more
    Jul 7, 2022

    Exhaled Breath Particles in Lung Cancer

    Recruiting
    • Lung Cancer
    • +3 more
    • EBPcollected using the PExA device.
    • Lund, Skåne Län, Sweden
      Skåne University Hospital
    May 24, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Efficiency and Safety of ICIs in Different Malignancies

    Recruiting
    • Melanoma
    • +3 more
    • Genetic tests of the available tumor and plasma samples
    • Moscow', Москва, Russian Federation
      N.N. Blokhin Russian Cancer Research Center
    Dec 26, 2021

    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

    Active, not recruiting
    • Adenocarcinoma of the Lung
    • +8 more
    • hypofractionated radiation therapy
    • +5 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Dec 2, 2021

    Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

    Recruiting
    • Lung Neoplasms
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 29, 2021

    Hepatocellular Carcinoma, Immunotherapy, CAR Trial in Guangzhou (GPC3 and/or TGFß targeting CAR-T cells)

    Recruiting
    • Hepatocellular Carcinoma
    • +5 more
    • GPC3 and/or TGFβ targeting CAR-T cells
    • Guangzhou, Guangdong, China
    • +1 more
    Nov 28, 2020

    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in United States (dietary

    Completed
    • Adenocarcinoma of the Lung
    • +7 more
    • soy isoflavones
    • +4 more
    • Bay City, Michigan
    • +4 more
    Nov 19, 2020

    Lung Cancer, NSCLC, Pulmonary Tumor Trial in Germany (ERDAFITINIB)

    Unknown status
    • Lung Cancer
    • +4 more
    • Gauting, Bavaria, Germany
    • +10 more
    Nov 11, 2020

    Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • +2 more
    • Hsp90 inhibitor AUY922
    • +3 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Sep 1, 2020

    Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IIIA NSCLC Trial (drug, other, genetic)

    Withdrawn
    • Recurrent Non-small Cell Lung Cancer
    • +5 more
    • (no location specified)
    Mar 30, 2020

    Squamous Cell Lung Cancer Trial in Bronx (Necitumumab-Gemcitabine-Cisplatin, Evaluation to determine if patient is a candidate

    Terminated
    Has Results
    • Squamous Cell Lung Cancer
    • Bronx, New York
      Montefiore Medical Center
    Mar 3, 2020

    EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion

    Unknown status
    • Squamous Cell Lung Cancer
    • EGFR mutation
    • Saint-Denis, Réunion
    • +2 more
    Feb 7, 2020

    Assessed With Liquid Biopsy of NSCLC Patients in China

    Completed
    • Lung Neoplasms
    • +3 more
      • Guangzhou, Guangdong, China
      • +13 more
      Feb 3, 2020

      Squamous Cell Lung Cancer, Lung Cancer, Pulmonary Disease Trial in Burlington (Optical Frequency Domain Imaging (OFDI) System)

      Withdrawn
      • Squamous Cell Lung Cancer
      • +2 more
      • Optical Frequency Domain Imaging (OFDI) System
      • Burlington, Massachusetts
        Lahey Clinic, Inc.
      Mar 8, 2019

      Lung Cancer Non-small Cell Stage IV, Squamous Cell Lung Cancer Trial in Shanghai, Beijing (AK105, Paclitaxel, Carboplatin)

      Unknown status
      • Lung Cancer Non-small Cell Stage IV
      • Squamous Cell Lung Cancer
      • AK105
      • +3 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 6, 2019

      Squamous Cell Lung Cancer, Lung Cancer Trial (Photodynamic Therapy (PDT))

      Withdrawn
      • Squamous Cell Lung Cancer
      • Lung Cancer
      • Photodynamic Therapy (PDT)
      • (no location specified)
      Jan 30, 2019

      Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in Winston-Salem (drug,

      Completed
      Has Results
      • Adenocarcinoma of the Lung
      • +8 more
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      May 30, 2018

      Optical Frequency Domain Imaging for Diagnosis of Central Airway

      Completed
      • Squamous Cell Lung Cancer
      • Lung Cancer
        • Boston, Massachusetts
          Massachusetts General Hospital
        Mar 20, 2018